10/30/20 5:56 PMNasdaq : HOLXHologic Awarded U.S. Government Contract to Expand COVID-19 Test Production CapacityHologic Awarded U.S. Government Contract to Expand COVID-19 Test Production CapacityRHEA-AIneutral
10/30/20 2:05 PMNasdaq : HGENHumanigen Announces First Patient Dosed at MedStar Washington Hospital Center in Phase 3 Clinical Study of Lenzilumab in COVID-19Humanigen, Inc. (HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm' with lenzilumab, today announced that MedStar Washington Hospital Center in Washington, D.C. treated its first COVID-19 patient with lenzilumab. The primary goal of this Phase 3 randomized, double-blind, multicenter, placebo-controlled clinical trial is to determine if lenzilumab can help hospitaRHEA-AIneutral
10/30/20 10:30 AMNasdaq : BHTGSeaDream Yacht Club Safely Completes First Voyage Utilizing Altapure AP-4 Disinfectant System Provided by BioHiTech as Part of Its COVID-19 Safety Protocols for CruisingBioHiTech Global, Inc. ("BioHiTech" or the "Company") (NASDAQ: BHTG), a sustainable technology and services company, announced today that the SeaDream Yacht Club ("SeaDream") completed its first voyage utilizing the Altapure AP-4(TM) high-levelRHEA-AIvery positive
10/30/20 9:00 AMNYSE : SPGIQ3 broadcast M&A market picks up pace in spite of COVID-19 pandemicU.S. broadcast station mergers and acquisitions (M&A) volume reached a total of $534.7 million in the third quarter of 2020 as tracked by Kagan, a media research group within S&P Global Market Intelligence. This level of activity constitutes a substantialRHEA-AIneutral
10/30/20 9:00 AMNasdaq : SVMKCarlex Glass Leverages SurveyMonkey Enterprise to Improve its Internal COVID-19 Communication and Keep its Worksites SafeSurveyMonkey's enterprise platform has beenRHEA-AIneutral
10/30/20 8:30 AMNYSE : ECLEcolab No-Rinse Sanitizer Kills COVID-19 Virus Faster Than Any Other ProductEcolab, the global leader in water, hygiene and infection prevention solutions and services, received approval from the U.S. Environmental Protection Agency (EPA) for its Sink & Surface Cleaner Sanitizer. The product is the first registered by the EPA to kill the virus that causes COVID-19 in 15 seconds - the fastest product available. Ecolab's advanced chemistries, including Sink & Surface Cleaner Sanitizer, are key to helping restaurants and other busRHEA-AIneutral
10/30/20 8:15 AMNasdaq : MDGSMedigus: Purex to Launch New COVID-19 Product Line on Amazon USAMedigus Ltd. (Nasdaq:MDGS) (TASE:MDGS), a technology company engaged in advanced medicalRHEA-AIneutral
10/30/20 8:00 AMNasdaq : APDNApplied DNA to Increase COVID-19 Surveillance Testing Utility for its Linea(TM) COVID-19 Assay Kits Through Expanded Use of Robotic AutomationApplied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics in vitro, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting, and anti-theft technology, today announced that it plans to boost its COVID-19 testing capacity at Applied DNA Clinical Laboratories, LLC ("ADCL"), its wholly-owned subsidiary, toRHEA-AIpositive
10/29/20 5:04 PMNasdaq : HBPHuttig Building Products, Inc. Announces Third Quarter 2020 Results and Provides Business Update on COVID-19 ImpactThird Quarter 2020 Highlights (as compared to prior year quarter): Net sales of $ 212.7 million compared to $215.7 million Reduced operating expenses by 13.5% to $35.8 million Operating income increased to $ 6.9 million compared to $ 3.3 million Generated cash from operations of $25.4 millionRHEA-AIneutral
10/29/20 4:13 PMNasdaq : EQEquillium Receives FDA Clearance of COVID-19 IND for Phase 3 TrialEquillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severeRHEA-AIneutral
10/29/20 4:10 PMNasdaq : MFNCMackinac Financial Corporation Reports 2020 Third Quarter Results and COVID-19 Operating UpdateMackinac Financial Corporation (Nasdaq: MFNC) ("we", or the "Corporation") the bank holding company for mBank ("the Bank") today announced 2020 third quarter net income of $3.32 million, or $.32 per share, compared to 2019 third quarter netRHEA-AIneutral
10/29/20 4:05 PMNYSE : CDRCedar Realty Trust Reports Third Quarter 2020 Results And COVID-19 UpdateCedar Realty Trust, Inc. (NYSE: CDR - the "Company") today reported results for the third quarter 2020. Net loss attributable to common shareholders was $(0.02) per diluted share compared to net loss of $(0.00) per diluted share for theRHEA-AIneutral
10/29/20 1:26 PMNYSE : GISGeneral Mills and its Foundation Expand COVID-19 Charitable Response to $14 Million Due to Growing Hunger RatesWith acute food insecurity expected to double worldwide in 2020 due to the COVID-19 pandemic, the General Mills Foundation announced an additional $4 million of philanthropic funding for nonprofit organizations working to alleviate growing food insecurity worldwide. The $4 million in supplemental funding is in addition to General Mills' charitable response since March 2020 of $10 million worth of grants from the General Mills Foundation and food donations from theRHEA-AIvery positive
10/29/20 11:56 AMNasdaq : JBLUJetBlue and Northwell Direct Partner to Provide Long-Term Health Solutions to COVID-19Northwell Direct and JetBlue, New York's Hometown Airline, (NASDAQ: JBLU) today announced that they are partnering to provide the airline with a comprehensive set of COVID-19 services and programs to support its crewmembers (employees) across JetBlue's operation and add a clinical layer to the airline's Safety From the Ground Up program. The customized set of solutions from Northwell Direct - a Northwell Health company that provides a broad range of healthRHEA-AIneutral
10/29/20 11:00 AMNYSE : UNHMore Than 40% of Americans Say COVID-19 Has Influenced What Health Plan They Intend to Select During Open EnrollmentMany Americans said COVID-19 has influenced the health plan they intend to select during open enrollment, while the majority report they are interested in using a smartphone or laptop to access medical services, according to a new UnitedHealthcare survey. These are some of the findings from the fifth-annual UnitedHealthcare Consumer Sentiment Survey, which examines Americans' attitudes and opinions about multiple areas of health care, including open enrollmenRHEA-AIneutral
10/29/20 10:05 AMNYSE : FDXFedEx Trade Index: Small Businesses View Trade, Technology as Avenues for Growth, Essential to COVID-19 RecoveryA majority of U.S. small business leaders think expanded trade between the United States and other countries creates opportunity and jobs in the U.S., notes the sixth FedEx Trade Index(1), a survey of 1,000 small business leaders which tracks the impact of international trade among the small business segment of the U.S. economy. The survey*, commissioned by FedEx Corp. (NYSE: FDX) and conducted by Morning Consult, finds 82% of U.S. small business decision makers belRHEA-AIpositive
10/29/20 10:00 AMNYSE : EPAM"HealthBuddy COVID-19" Mobile App Now Available in Apple, Google Play StoresWHAT: UNICEF and EPAM's new 'HealthBuddy COVID-19' chatbot app --developed by the United Nations Children's Fund/ Europe and Central Asia Regional Office (UNICEF ECARO), as a reliable source of information and advice related to COVID-19--is now availableRHEA-AIneutral
10/29/20 9:10 AMNasdaq : ONCSOncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for a first-in-human Phase 1 trial forRHEA-AIneutral
10/29/20 9:00 AMNYSE : FITFitbit Receives Army Award to Help Accelerate its COVID-19 Wearable Detection TechnologyFitbit (NYSE: FIT) Fitbit announced today it has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly $2.5 million from the U.S. Department of Defense through a Medical Technology Enterprise Consortium (MTEC) award to advance development of a wearable diagnostic capability for the early detection of a COVID-19 infection. As part of the award, Fitbit is working to initiate a prospective study with Northwell Health's FRHEA-AIpositive
10/29/20 8:30 AMAMEX : DXROREGON HEALTH & SCIENCE UNIVERSITY JOINS MULTICENTER COVID-19 BVA-100(R) STUDYDaxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operationsRHEA-AIneutral
10/29/20 8:30 AMNasdaq : CRVSCorvus Pharmaceuticals to Present Updated Data from its Clinical Trial of CPI-006 for Patients with COVID-19 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual MeetingCorvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, todayRHEA-AIneutral
10/29/20 8:05 AMNasdaq : BIOCBiocept Provides Update on COVID-19 Testing with More than 80,000 Samples ReceivedBiocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces an update on its COVID-19 testing with more than 80,000 samples received to date for processingRHEA-AIneutral
10/29/20 7:30 AMNasdaq : MBRXMoleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced it has entered into an agreement with theRHEA-AIpositive
10/29/20 7:00 AMNasdaq : HGENHumanigen Announces First Patient Dosed in NIH ACTIV-5/Big Effect Trial Evaluating Lenzilumab(TM) for COVID-19Humanigen, Inc., (Nasdaq: HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' today announced that the first patient has been dosed at the Emory University School of Medicine in Atlanta, Georgia as part of the in the ACTIV-5 "Big Effect Trial" (ACTIV-5/BET) evaluating lenzilumab with remdesivir, compared to placebo and remdesivir, in patients hospitalized with CORHEA-AIneutral
10/29/20 7:00 AMNasdaq : UALUnited Airlines Launches World's First Free Transatlantic COVID-19 Testing PilotUnited Airlines today announced the world's first free transatlantic COVID-19 testing pilot program for customers. From November 16 through December 11, the airline will offer rapid tests to every passenger over 2 years old and crew members on boardRHEA-AIneutral
10/29/20 6:45 AMAMEX : ANVSAnnovis Bio Resumes Treatment of Patients in Ongoing Phase 2a Study in Alzheimer's Disease after COVID-Related DelayAnnovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced it resumed treatment of patients in its Phase 2aRHEA-AIneutral
10/29/20 2:00 AMNasdaq : MRNAModerna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) to JapanModerna partners with Takeda and the government of Japan to supply 50 million doses of mRNA vaccine against COVID-19 (mRNA-1273) to Japan.RHEA-AIneutral
10/29/20 12:41 AMNYSE : WRIWeingarten Realty Reports Third Quarter Results and Provides COVID-19 UpdateWeingarten Realty (NYSE: WRI) reports third quarter results and provides COVID-19 update.RHEA-AIneutral
10/28/20 5:16 PMNYSE : LLYData for Lilly's bamlanivimab (LY-CoV555) in COVID-19 outpatients published in New England Journal of MedicineThe New England Journal of Medicine has published data from the monotherapy arms of BLAZE-1, a Phase 2 study assessing the efficacy and safety of Eli Lilly and Company's (NYSE: LLY) bamlanivimab (LY-CoV555) - a neutralizing antibody - in the COVID-19RHEA-AIneutral
10/28/20 5:00 PMNasdaq : REGNRegeneron's COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus Levels and Need for Further Medical AttentionToday's data, involving an additional 524 patients from the ongoing Phase 2/3 trial, provides definitive final virology results and meets the clinical endpoint of reducing medical visitsRegeneron has shared these results with the U.S. FDA, which isRHEA-AIneutral
10/28/20 10:30 AMNYSE : IBMIBM Study: AI-driven Virtual Agents Can Drive Customer Satisfaction and Cost Savings Amid COVID-19As many organizations across the world look to digital tools to help address surges in customer inquiries due to the COVID-19 pandemic, a new IBM study revealed 99% of respondents report an increase in customer satisfaction as a result of using AI-drivenRHEA-AIneutral
10/28/20 9:00 AMNYSE : TDCOVID-19 Hammers Corporate Outlook While Catalyzing Technology Expansion, According to TD Bank and Strategic Treasurer Annual SurveyWhile companies hinted at waning optimism in 2019, COVID-19's impact on almost every aspect of business operations led to a significantly more negative organizational outlook, according to the 2020 Treasury Perspectives survey, releasedRHEA-AIneutral
10/28/20 9:00 AMNYSE : IPGNearly Two-Thirds of American Workers Are Planning a Professional Change as a Result of COVID-19In the fifth wave of a national survey among American adults, Weber Shandwick and United Minds, the firm's management consultancy specializing in transformation, in partnership with KRC Research, have found that 61 percent of U.S. workers are contemplatingRHEA-AIneutral
10/28/20 9:00 AMNasdaq : QLGNQualigen Therapeutics Receives Positive Pre-IND Response from FDA for the Clinical Development of AS1411 as a Treatment for COVID-19Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced receipt of written feedback to its Type B Pre-IND (Pre-Investigational New Drug application) meeting request from the U.S. Food and Drug Administration (FDA) that is in general agreement withRHEA-AIneutral
10/28/20 8:30 AMNYSE : PRIIn the Face of COVID-19, Primerica Survey Finds American Families Have Mixed Feelings About Personal FinancesPrimerica Q3 2020 Survey ResultsRHEA-AIneutral
10/28/20 8:30 AMNasdaq : EXLSEXL Named as 2020 Cummins COVID-19 Outstanding SupplierEXL [NASDAQ: EXLS], a leading operations management and analytics company, today announced that it has been recognized by Cummins Inc. [NYSE: CMI] as a 2020 Cummins COVID-19 Outstanding Supplier. "We at Cummins would like to recognize EXL forRHEA-AIneutral
10/28/20 8:00 AMNasdaq : NXGNNextGen(R) Health Data Hub Enables Arizona's First Ever COVID-19 Alerts for Community-Wide Data Exchange During PandemicArizona's Statewide HIE, Health Current, Leverages NextGen Healthcare's Platform to Send Real-Time Alerts on COVID-19 Test ResultsRHEA-AIneutral
10/28/20 8:00 AMNasdaq : XSPAXpresSpa Group Opens XpresCheck(TM) COVID-19 Testing Facility at Logan International Airport in Boston TodayXpresSpa Group, Inc. (Nasdaq: XSPA) ("XpresSpa" or the "Company"), a health and wellness company, in conjunction withRHEA-AIneutral
10/28/20 8:00 AMNasdaq : RNWKSAFR(R) from RealNetworks Launches Version 3.0 Featuring Enhanced COVID-19 Response Features and a New High Sensitivity Face DetectorSAFR from RealNetworks, Inc. (NASDAQ: RNWK) today announced improved face detection and recognition accuracy for both masked and unmasked faces with the release of SAFR 3.0. Available now, SAFR'sRHEA-AIneutral
10/28/20 7:30 AMNasdaq : RNLX, TECHEKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the UK and EuropeKantaro Biosciences, LLC ("Kantaro"), a joint venture between the Mount Sinai Health System and RenalytixAI plc (LSE: RENX / NASDAQ: RNLX), and manufacturing partner Bio-Techne Corporation (NASDAQ: TECH), entered into a two-year marketing and distributionRHEA-AIneutral
10/28/20 7:30 AMNYSE : CVSCVS Health Expands COVID-19 Testing Services with Plans to Add Nearly 1,000 Rapid-result Test Sites at Select CVS Pharmacy LocationsAs part of CVS Health's (NYSE: CVS) ongoing effort to increase access to COVID-19 testing and help slow the spread of the virus, the company today announced plans to expand COVID-19 testing services currently offered at select CVS Pharmacy locationsRHEA-AIneutral
10/28/20 7:30 AMAMEX : AMPEAmpio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory DistressAmpio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced today the Company has begun recruiting and enrolling patients in aRHEA-AIneutral
10/28/20 7:15 AMNYSE : SAICSAIC Launches R3 Solution Suite to Help Government Agencies Respond to New Demands Presented by the COVID-19 PandemicScience Applications International Corp. (NYSE: SAIC) today announced the availability of the SAIC R3 portfolio of solutions designed to help federal government customers meet new work challenges and opportunities related to remote work, resiliency, and digital government services resulting from the COVID-19 pandemic. The SAIC R3 solutions - available now - are designed to help the government Respond, Recover, and Restructure by addressing the life cycle of challenRHEA-AIneutral
10/28/20 7:06 AMNYSE : KRKroger Health Launches COVID-19 Rapid Antibody Testing at Pharmacy LocationsKroger Health, the healthcare division of The Kroger Co. (NYSE: KR), today announced the launch of rapid antibody testing across its family of pharmacies, expanding the company's existing portfolio of in-clinic and at-home COVID-19 diagnostic tests, to helpRHEA-AIneutral
10/28/20 6:45 AMNYSE : LLYLilly announces agreement with U.S. government to supply 300,000 vials of investigational neutralizing antibody bamlanivimab (LY-CoV555) in an effort to fight COVID-19Eli Lilly and Company (NYSE: LLY) announced today an initial agreement with the U.S. government to supply 300,000 vials of bamlanivimab (LY-CoV555) 700 mg, an investigational neutralizing antibody, for $375 million. The U.S. government will accept theRHEA-AIvery positive
10/28/20 6:00 AMNYSE : ANTMAnthem Reports Third Quarter Results, Reaffirms Commitment to Stakeholders During COVID-19 PandemicAnthem, Inc. (NYSE: ANTM) reported third quarter 2020 results that reflect the impacts of ongoing COVID-19 costs and the continued recovery in healthcare utilization while upholding its commitment to addressing financial imbalances for its health plan members, customers, care providers, associates, and local communities. "Against the backdrop of the ongoing pandemic, Anthem and its dedicated associates have continued to respond quickly and with compassion to meetRHEA-AIneutral
10/27/20 4:15 PMNYSE : AATAmerican Assets Trust, Inc. Reports Third Quarter 2020 Financial Results and COVID-19 Operational UpdateNet income available to common stockholders of $5.0 million and $24.8 million for the three and nine months ended September 30, 2020, respectively, or $0.08 and $0.41 per diluted share, respectively Funds From Operations per diluted share decreased 23% and 9% year-over-year for the three and nineRHEA-AIneutral
10/27/20 4:05 PMNasdaq : AUPHAurinia Announces European Investigator-Initiated Trial to Evaluate Antiviral Activity of Voclosporin in Kidney Transplant Recipients with COVID-19Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today announced the funding and initiation of an open-label exploratory trial evaluating the antiviral effects of voclosporin in kidney transplant recipients (KTRs) with COVID-19 (SARS-CoV-2) - the VOCOVID study. The single-center, investigator-initiated trialRHEA-AIneutral
10/27/20 4:05 PMNasdaq : QCRHQCR Holdings, Inc. Announces Record Third Quarter Earnings Despite Elevated COVID-19 Provisioning EPS of $1.09 Driven by Record Pre-Provision/Pre-Tax Adjusted Net Income Third Quarter 20 20 Highlights Record n et income of $ 1 7.3 million, or $ 1.09 per diluted share Adjusted net income (non-GAAP) of $ 1 7.7 million, or $ 1.11 per diluted share Record n oninterest income of $ 38.0 million ,RHEA-AIneutral
10/27/20 11:35 AMNYSE : SCHWSchwab Independent Advisor Outlook Study Indicates Advisors Remain Optimistic Despite Challenges of COVID-19 EnvironmentAccording to the latest findings from Schwab's Independent Advisor Outlook Study (IAOS), advisors remain optimistic despite challenges from COVID-19.RHEA-AIneutral
